MedPath

Exercise and PRP vs Exercise Alone in Patients With Knee Osteoarthritis

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Interventions
Other: Exercise
Biological: PRP
Registration Number
NCT04697667
Lead Sponsor
Istanbul University - Cerrahpasa (IUC)
Brief Summary

This study is a prospective randomized controlled study of different treatments for knee osteoarthritis and aims to investigate the efficacy of exercise combined platelet rich plasma (PRP) injection versus only exercise or only PRP treatments.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
84
Inclusion Criteria
  • Adults 40-70 years of age,
  • Grade 2-3 according to Kellgren Lawrence osteoarthritis classification,
  • No medication for knee osteoarthritis in the past three months,
  • Subjects who understand and sign the consent form for this study.
Exclusion Criteria
  • Patients who have received an invasive procedure, intra-articular application and / or physiotherapy in the target knee within three months,
  • Previous partial or total knee replacement of the target knee,
  • Body mass index > 30 kg/m2,
  • Having any cardiovascular diseases, neurological disorders, rheumatic diseases, malignancy or psychiatric diseases,
  • Impaired cognition that impacts the ability to give informed consent,
  • Participation in another clinical trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group IExerciseEach subject in this group will receive a combined treatment protocol consisting of three PRP injections to knee joint and supervised exercise program.
Group IIExerciseEach subject in this group will receive a treatment of supervised exercise program.
Group IIIPRPEach subject in this group will receive a treatment of three PRP injections to knee joint.
Group IPRPEach subject in this group will receive a combined treatment protocol consisting of three PRP injections to knee joint and supervised exercise program.
Primary Outcome Measures
NameTimeMethod
Pain intensity3rd month

Pain intensity will be measured using the numerical pain rating scale. Patients are asked to circle the number between 0 and 10 that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.

Function3rd month

Functional status of the patients will be evaluated by The Western Ontario and McMaster Universities Arthritis (WOMAC) Index. It is a self-administered questionnaire consisting of 24 items divided into 3 subscales (Pain, Stiffness and Physical Function). The test questions are scored on a scale of 0-4, which correspond to: None (0), Mild (1), Moderate (2), Severe (3), and Extreme (4). Higher scores on the WOMAC indicate worse results.

Functional performance - 40m fast-paced walk test3rd month

Functional performance of the patients will be evaluated by 40-meter fast-paced walk test. Participants are asked to walk as quickly but as safely as possible, without running, along a 10-meter walkway for a total distance of 40 meters. Walking speed will be measured in meters/second (m/s).

Functional performance - 10-step stair-climb test3rd month

Functional performance of the patients will be evaluated by 10-step stair-climb test. Patients are instructed to ascend and descend the flight of stairs as quickly as possible but in a safe manner. The time needed is recorded in seconds.

Secondary Outcome Measures
NameTimeMethod
Range of motion3rd month

Knee joint ROMs will be measured using a universal goniometer. The process will be repeated three times and the average value will be recorded.

Patient Satisfaction3rd month

Patient satisfaction will be assessed by the Global Rating of Change scale.

Health related quality of life3rd month

Health related quality of life will be measured using SF 12 score that measures eight health domains to assess physical and mental health.

Trial Locations

Locations (1)

Istanbul University-Cerrahpasa

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath